-
BioTime Inc. (BTX)
- P/E (TTM): 2.0X
- View BTX Profile
- View Questions on BTX
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Costco Wholesale Corporation (COST $915.31)
- $915.31 P/E (TTM): 63.83X Cap: $391.75B
- View COST Profile
- View Questions on COST
-
Intuitive Surgical Inc. (ISRG $585.08)
- $585.08 P/E (TTM): 78.32X Cap: $209.95B
- View ISRG Profile
- View Questions on ISRG
-
NVIDIA Corporation (NVDA $185.04)
- $185.04 P/E (TTM): 46.46X Cap: $4.59T
- View NVDA Profile
- View Questions on NVDA
-
Booking Holdings Inc. (BKNG $5,445.00)
- $5,445.00 P/E (TTM): 34.84X Cap: $175.53B
- View BKNG Profile
- View Questions on BKNG
-
Eli Lilly and Company (LLY $1,085.19)
- $1,085.19 P/E (TTM): 52.06X Cap: $1.04T
- View LLY Profile
- View Questions on LLY
-
BioTime Inc. (BTX)
- P/E (TTM): 2.0X
- View BTX Profile
- View Questions on BTX
-
Microsoft CDR (CAD Hedged) (MSFT $34.01)
- $34.01 P/E (TTM): 35.08X Cap: $4.91T
- View MSFT Profile
- View Questions on MSFT
Q: I currently hold MSFT, NVIDIA and COST in my TFSA. I took a loss on BTX and now have cash to reinvest.
Should I buy more of the above 3 or diversify and if so any suggestions without making specific recommendations
Should I buy more of the above 3 or diversify and if so any suggestions without making specific recommendations
Insiders
Share Information
SEC Filings
News and Media